Seeking Alpha

Acorda Therapeutics (ACOR) is out with findings from a study assessing a Diazepam nasal spray in...

Acorda Therapeutics (ACOR) is out with findings from a study assessing a Diazepam nasal spray in patients with epilepsy who experience cluster seizures. The study shows the drug is well absorbed from the nasal cavity and "had a similar pharmacokinetic profile regardless of when administered relative to the seizure episode." (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector